Search research articles
Contact Us
Filters
Showing results (61-70 of 207) with videos related to
Page
of 21
Sort By:
Serican Journal of Medicine
|
April 13, 2026
Conditionally Reprogrammed Cells Preserve Cellular Diversity and Permit Genetic Manipulation: Implications for Cancer Heterogeneity and Tissue Regeneration
Shuang Fang, Guangzhao Li, Dilber Nurmurmet, et al.
The Journal of Biological Chemistry
|
May 27, 2016
Reprogramming Nurse-like Cells with Interferon γ to Interrupt Chronic Lymphocytic Leukemia Cell Survival
Shalini Gautam, Kavin Fatehchand, Saranya Elavazhagan, et al.
Cancer Immunology Research
|
June 12, 2016
Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells
Rebekah L Browning, William H Byrd, Nikhil Gupta, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 19, 2013
Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties
Sarwish Rafiq, Jonathan P Butchar, Carolyn Cheney, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 13, 2022
Spinal Cord Injury Impairs Lung Immunity in Mice
Katherine A Mifflin, Faith H Brennan, Zhen Guan, et al.
Molecular Cancer Therapeutics
|
July 27, 2016
A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer
Erin M Bertino, Elizabeth L McMichael, Xiaokui Mo, et al.
Cancer Genetics
|
April 16, 2011
Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate
Natarajan Muthusamy, Heather Breidenbach, Leslie Andritsos, et al.
Pediatric Blood & Cancer
|
April 3, 2015
Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma
Doris Phelps, Kathryn Bondra, Star Seum, et al.
Cancer Research
|
July 5, 2014
AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis
Chih-Chien Chou, Kuen-Haur Lee, I-Lu Lai, et al.
Plos One
|
July 21, 2017
Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells
Kavin Fatehchand, Ramasamy Santhanam, Brenda Shen, et al.
Page
of 21
Search research articles
Search
Showing results (61-70 of 207) with videos related to
Sort By:
Page
of 21
Serican Journal of Medicine
|
April 13, 2026
Conditionally Reprogrammed Cells Preserve Cellular Diversity and Permit Genetic Manipulation: Implications for Cancer Heterogeneity and Tissue Regeneration
Shuang Fang, Guangzhao Li, Dilber Nurmurmet, et al.
The Journal of Biological Chemistry
|
May 27, 2016
Reprogramming Nurse-like Cells with Interferon γ to Interrupt Chronic Lymphocytic Leukemia Cell Survival
Shalini Gautam, Kavin Fatehchand, Saranya Elavazhagan, et al.
Cancer Immunology Research
|
June 12, 2016
Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells
Rebekah L Browning, William H Byrd, Nikhil Gupta, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 19, 2013
Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties
Sarwish Rafiq, Jonathan P Butchar, Carolyn Cheney, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 13, 2022
Spinal Cord Injury Impairs Lung Immunity in Mice
Katherine A Mifflin, Faith H Brennan, Zhen Guan, et al.
Molecular Cancer Therapeutics
|
July 27, 2016
A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer
Erin M Bertino, Elizabeth L McMichael, Xiaokui Mo, et al.
Cancer Genetics
|
April 16, 2011
Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate
Natarajan Muthusamy, Heather Breidenbach, Leslie Andritsos, et al.
Pediatric Blood & Cancer
|
April 3, 2015
Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma
Doris Phelps, Kathryn Bondra, Star Seum, et al.
Cancer Research
|
July 5, 2014
AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis
Chih-Chien Chou, Kuen-Haur Lee, I-Lu Lai, et al.
Plos One
|
July 21, 2017
Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells
Kavin Fatehchand, Ramasamy Santhanam, Brenda Shen, et al.
Page
of 21